KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash & Current Investments (2016 - 2025)

Globus Medical (GMED) has disclosed Cash & Current Investments for 15 consecutive years, with $557.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments fell 37.39% year-over-year to $557.2 million, compared with a TTM value of $557.2 million through Dec 2025, down 37.39%, and an annual FY2025 reading of $557.2 million, down 37.39% over the prior year.
  • Cash & Current Investments was $557.2 million for Q4 2025 at Globus Medical, up from $18.8 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $890.1 million in Q4 2024 and bottomed at $18.8 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $474.5 million, with a median of $468.9 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments surged 71.9% in 2024, then plummeted 97.3% in 2025.
  • Year by year, Cash & Current Investments stood at $443.4 million in 2021, then grew by 0.59% to $446.1 million in 2022, then increased by 16.08% to $517.8 million in 2023, then soared by 71.9% to $890.1 million in 2024, then crashed by 37.39% to $557.2 million in 2025.
  • Business Quant data shows Cash & Current Investments for GMED at $557.2 million in Q4 2025, $18.8 million in Q3 2025, and $229.4 million in Q2 2025.